GlaxoSmithKline Debt to Equity Ratio:
2.886 for March 31, 2013GlaxoSmithKline Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 2.886 |
| Dec. 31, 2012 | 3.150 |
| Sept. 30, 2012 | 2.810 |
| June 30, 2012 | 2.443 |
| March 31, 2012 | 1.677 |
| Dec. 31, 2011 | 1.855 |
| Sept. 30, 2011 | 2.026 |
| June 30, 2011 | 1.759 |
| March 31, 2011 | 1.663 |
| Dec. 31, 2010 | 1.699 |
| Sept. 30, 2010 | 1.553 |
| June 30, 2010 | 1.745 |
| March 31, 2010 | 1.523 |
| Dec. 31, 2009 | 1.625 |
| Sept. 30, 2009 | 1.823 |
| June 30, 2009 | 1.847 |
| March 31, 2009 | 2.032 |
| Dec. 31, 2008 | 2.041 |
| Sept. 30, 2008 | 1.895 |
| June 30, 2008 | 1.845 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
GSK Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Pfizer | 0.461 |
| Sanofi | |
| AstraZeneca | 0.458 |
GSK Debt to Equity Ratio Rankings
| Overall |
43rd percentile 4490 of 8007 |
| Sector |
23rd percentile 522 of 685 in Healthcare |
| Industry |
29th percentile 38 of 54 in Drug Manufacturers - Major |
GSK Debt to Equity Ratio Range, Past 5 Years
| Minimum | 1.523 | Mar 2010 |
| Maximum | 3.150 | Dec 2012 |
| Average | 1.995 |
